These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9024406)
1. HIV vaccines. Ellenberg SS; Rida WN Lancet; 1997 Feb; 349(9048):361. PubMed ID: 9024406 [No Abstract] [Full Text] [Related]
2. Low-efficacy HIV vaccines: potential for community-based intervention programmes. Anderson RM; Garnett GP Lancet; 1996 Oct; 348(9033):1010-3. PubMed ID: 8855867 [TBL] [Abstract][Full Text] [Related]
3. Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial. Gust DA; Wiegand RE; Kretsinger K; Sansom S; Kilmarx PH; Bartholow BN; Chen RT AIDS; 2010 May; 24(8):1135-43. PubMed ID: 20168206 [TBL] [Abstract][Full Text] [Related]
4. Is population-level perversity a likely outcome of mass vaccination against HIV? Bogaards JA; van Ballegooijen WM; Jan Weverling G; Boerlijst MC; Goudsmit J Lancet Infect Dis; 2005 May; 5(5):254; author reply 255-6. PubMed ID: 15854875 [No Abstract] [Full Text] [Related]
5. HIV vaccination dilemma. Sabin AB Nature; 1993 Mar; 362(6417):212. PubMed ID: 8318105 [No Abstract] [Full Text] [Related]
7. Time to take stock in HIV/AIDS prevention. Kalichman SC AIDS Behav; 2008 May; 12(3):333-4. PubMed ID: 18360742 [No Abstract] [Full Text] [Related]
8. HIV vaccine trials: reconsidering the therapeutic misconception and the question of what constitutes trial related injuries. Schüklenk U; Ashcroft R Dev World Bioeth; 2007 Dec; 7(3):ii-iv. PubMed ID: 18021115 [No Abstract] [Full Text] [Related]
9. Suppressing HIV transmission--through behavior and biology. Laurence J AIDS Read; 2006 May; 16(5):231-2. PubMed ID: 16764062 [No Abstract] [Full Text] [Related]
10. Preparations for AIDS vaccine trials. Developing brief valid screening instruments for HIV-related sexual risk behavior among gay and bisexual men. McKirnan DJ; Doetsch J; Vanable P; Buchbinder S; Douglas JM; Judson F AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S285-8. PubMed ID: 7865320 [TBL] [Abstract][Full Text] [Related]
11. From Don Giovanni to Magic Johnson: methodological conundrums in the measurement of sexual risk behavior. Patterson TL; Strathdee SA Ann Behav Med; 2005 Apr; 29(2):83-5. PubMed ID: 15823780 [No Abstract] [Full Text] [Related]
13. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda. Vlahov D AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S3-6. PubMed ID: 7865324 [TBL] [Abstract][Full Text] [Related]
14. Determinants of safe and risk-taking sexual behavior among gay men: a review. Hospers HJ; Kok G AIDS Educ Prev; 1995 Feb; 7(1):74-96. PubMed ID: 7772458 [TBL] [Abstract][Full Text] [Related]
16. The potential impact of an HIV vaccine with limited protection on HIV incidence in Thailand: a modeling study. Nagelkerke NJ; Hontelez JA; de Vlas SJ Vaccine; 2011 Aug; 29(36):6079-85. PubMed ID: 21718745 [TBL] [Abstract][Full Text] [Related]
17. Study looks at how HIV may spread through oral sex. AIDS Read; 2003 May; 13(5):207-8. PubMed ID: 12800822 [No Abstract] [Full Text] [Related]
18. Potential pitfalls on the road to an effective HIV vaccine. Schwartz DH Immunol Today; 1994 Feb; 15(2):54-7. PubMed ID: 7908803 [TBL] [Abstract][Full Text] [Related]
19. HIV/AIDS. ARVs as HIV prevention: a tough road to wide impact. Shelton JD Science; 2011 Dec; 334(6063):1645-6. PubMed ID: 22194560 [No Abstract] [Full Text] [Related]
20. Project ROADMAP: Reeducating Older Adults in Maintaining AIDS Prevention: a secondary intervention for older HIV-positive adults. Illa L; Echenique M; Jean GS; Bustamante-Avellaneda V; Metsch L; Mendez-Mulet L; Eisdorfer C; Sanchez-Martinez M AIDS Educ Prev; 2010 Apr; 22(2):138-47. PubMed ID: 20387984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]